Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2022-02-14 | New | $10,569,989 | $10,569,989 | Equity Only | 06b | SEC link |
| 2020-11-05 | Amended | $20,000,000 | $7,504,918 | Debt Only | 06b | SEC link |
| 2020-07-14 | New | $12,495,082 | $12,495,082 | Debt Only | 06b | SEC link |
| 2018-07-20 | New | $7,000,000 | $7,000,000 | Equity Only | 06b | SEC link |
| 2017-10-02 | New | $7,000,000 | $7,000,000 | Equity Only | 06b | SEC link |
| 2016-12-06 | New | $350,000 | $350,000 | Debt Only | 06b | SEC link |
| 2016-04-15 | Amended | $1,333,618 | $1,183,230 | Equity Only | 06b | SEC link |
| 2016-01-27 | New | $150,388 | $150,388 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Bary Bailey | Director |
| Chuck Bramlage | Director |
| Paul Garofolo | Director, Executive |
| Geoffrey Glass | Director |
| David Johnston | Director |
| Joseph Nixon | Executive |
| David Ousterout | Executive |
| Stuart Peterson | Director |
| Nick Taylor | Executive |